Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
LEVOMETHADYL ACETATE
(1993)
Small molecule
Unknown
Unknown
Approved
Substance-Related Disorders
LEVOMETHADYL ACETATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
R3B637Y991
Molecule Type:
Small molecule
Molecular Formula:
C23H31NO2
Molecular Weight:
353.51
AlogP:
4.65
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
FLUVASTATIN SODIUM
(1993)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Hypercholesterolemia; Hyperlipoproteinemia Type II
FLUVASTATIN SODIUM
×
Maximum Phase:
4
First Approval:
1993
UNII:
PYF7O1FV7F
Molecule Type:
Small molecule
Molecular Formula:
C24H25FNNaO4
Molecular Weight:
433.45
AlogP:
4.63
PSA:
82.69
HBD:
3.0
HBA:
#RotB:
8.0
Source:
FLUVASTATIN
(1993)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
FLUVASTATIN
×
Maximum Phase:
4
First Approval:
1993
UNII:
4L066368AS
Molecule Type:
Small molecule
Molecular Formula:
C24H26FNO4
Molecular Weight:
411.47
AlogP:
4.63
PSA:
82.69
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DICLOFENAC POTASSIUM
(1993)
Small molecule
Cyclooxygenase inhibitor
Unknown
Approved
Acute Pain; Arthritis, Rheumatoid; Migraine Disorders; Osteoarthritis; Pain
DICLOFENAC POTASSIUM
×
Maximum Phase:
4
First Approval:
1993
UNII:
L4D5UA6CB4
Molecule Type:
Small molecule
Molecular Formula:
C14H10Cl2KNO2
Molecular Weight:
334.24
AlogP:
4.36
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LEVOCABASTINE HYDROCHLORIDE
(1993)
Small molecule
Histamine H1 receptor antagonist
OPHTHALMIC
Approved
Unknown
LEVOCABASTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
124XMA6YEI
Molecule Type:
Small molecule
Molecular Formula:
C26H30ClFN2O2
Molecular Weight:
456.99
AlogP:
4.89
PSA:
64.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PERINDOPRIL
(1993)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PERINDOPRIL
×
Maximum Phase:
4
First Approval:
1993
UNII:
Y5GMK36KGY
Molecule Type:
Small molecule
Molecular Formula:
C19H32N2O5
Molecular Weight:
368.47
AlogP:
1.94
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
8.0
Source:
RIBOFLAVIN
(1993)
Small molecule
Unknown
Unknown
Approved
Anemia; Anemia, Iron-Deficiency; Eye Diseases; Folic Acid Deficiency; Kidney Failure, Chronic
RIBOFLAVIN
×
Maximum Phase:
4
First Approval:
1993
UNII:
TLM2976OFR
Molecule Type:
Small molecule
Molecular Formula:
C17H20N4O6
Molecular Weight:
376.37
AlogP:
-1.72
PSA:
161.56
HBD:
5.0
HBA:
#RotB:
5.0
Source:
CLADRIBINE
(1993)
Small molecule
DNA inhibitor
INJECTION; ORAL
Approved
Anemia; Immune System Diseases; Leukemia, Hairy Cell; Multiple Sclerosis; Neoplasms
CLADRIBINE
×
Maximum Phase:
4
First Approval:
1993
UNII:
47M74X9YT5
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O3
Molecular Weight:
285.69
AlogP:
-0.3
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
STRONTIUM CHLORIDE
(1993)
Small molecule
Unknown
Unknown
Approved
Unknown
STRONTIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
EKE8PS9J6Z
Molecule Type:
Small molecule
Molecular Formula:
Cl2Sr
Molecular Weight:
158.53
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TACRINE HYDROCHLORIDE
(1993)
Small molecule
Cholinesterases; ACHE & BCHE inhibitor
ORAL
Approved
Unknown
TACRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
4966RNG0BU
Molecule Type:
Small molecule
Molecular Formula:
C13H15ClN2
Molecular Weight:
234.73
AlogP:
2.7
PSA:
38.91
HBD:
1.0
HBA:
#RotB:
0.0
Source:
FELBAMATE
(1993)
Small molecule
Glutamate [NMDA] receptor antagonist
ORAL
Approved
Anemia; Epilepsy; Seizures
FELBAMATE
×
Maximum Phase:
4
First Approval:
1993
UNII:
X72RBB02N8
Molecule Type:
Small molecule
Molecular Formula:
C11H14N2O4
Molecular Weight:
238.24
AlogP:
0.96
PSA:
104.64
HBD:
2.0
HBA:
#RotB:
5.0
Source:
VENLAFAXINE HYDROCHLORIDE
(1993)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Anxiety Disorders; Depressive Disorder; Depressive Disorder, Major; Panic Disorder; Phobia, Social
VENLAFAXINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1993
UNII:
7D7RX5A8MO
Molecule Type:
Small molecule
Molecular Formula:
C17H28ClNO2
Molecular Weight:
313.87
AlogP:
3.04
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FLUDEOXYGLUCOSE F 18
(1994)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
FLUDEOXYGLUCOSE F 18
×
Maximum Phase:
4
First Approval:
1994
UNII:
0Z5B2CJX4D
Molecule Type:
Small molecule
Molecular Formula:
C6H11FO5
Molecular Weight:
181.15
AlogP:
-2.24
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
1.0
Source:
VINORELBINE TARTRATE
(1994)
Small molecule
Tubulin inhibitor
INJECTION
Approved
Unknown
VINORELBINE TARTRATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
253GQW851Q
Molecule Type:
Small molecule
Molecular Formula:
C53H66N4O20
Molecular Weight:
1079.12
AlogP:
4.75
PSA:
133.87
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CYSTEAMINE BITARTRATE
(1994)
Small molecule
Cystine reducing agent
ORAL
Approved
Cystinosis
CYSTEAMINE BITARTRATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
QO84GZ3TST
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO6S
Molecular Weight:
227.24
AlogP:
-0.13
PSA:
26.02
HBD:
2.0
HBA:
#RotB:
1.0
Source:
IOBENGUANE SULFATE I 131
(1994)
Small molecule
Unknown
Unknown
Approved
Unknown
IOBENGUANE SULFATE I 131
×
Maximum Phase:
4
First Approval:
1994
UNII:
M575VKV19N
Molecule Type:
Small molecule
Molecular Formula:
C16H22I2N6O4S
Molecular Weight:
656.27
AlogP:
1.27
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ROCURONIUM
(1994)
Small molecule
Unknown
Unknown
Approved
Unknown
ROCURONIUM
×
Maximum Phase:
4
First Approval:
1994
UNII:
WRE554RFEZ
Molecule Type:
Small molecule
Molecular Formula:
C32H53N2O4+
Molecular Weight:
529.79
AlogP:
4.41
PSA:
59.0
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ANTAZOLINE
(1994)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity; Nasal Obstruction
ANTAZOLINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
DHA8014SS1
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3
Molecular Weight:
265.36
AlogP:
2.69
PSA:
27.63
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PHENIRAMINE MALEATE
(1994)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Unknown
PHENIRAMINE MALEATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
NYW905655B
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O4
Molecular Weight:
356.42
AlogP:
3.17
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
SPIRAPRIL HYDROCHLORIDE
(1994)
Small molecule
Angiotensin-converting enzyme inhibitor
ORAL
Approved
Unknown
SPIRAPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
OCC25LM897
Molecule Type:
Small molecule
Molecular Formula:
C22H31ClN2O5S2
Molecular Weight:
503.09
AlogP:
2.39
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
DORZOLAMIDE HYDROCHLORIDE
(1994)
Small molecule
Carbonic anhydrase II inhibitor
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
DORZOLAMIDE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
QZO5366EW7
Molecule Type:
Small molecule
Molecular Formula:
C10H17ClN2O4S3
Molecular Weight:
360.91
AlogP:
0.61
PSA:
106.33
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ROCURONIUM BROMIDE
(1994)
Small molecule
Muscle-type nicotinic acetylcholine receptor antagonist
INJECTION
Approved
Unknown
ROCURONIUM BROMIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
I65MW4OFHZ
Molecule Type:
Small molecule
Molecular Formula:
C32H53BrN2O4
Molecular Weight:
609.69
AlogP:
4.41
PSA:
59.0
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CYSTEAMINE
(1994)
Small molecule
Unknown
Unknown
Approved
Eye Diseases
CYSTEAMINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
5UX2SD1KE2
Molecule Type:
Small molecule
Molecular Formula:
C2H7NS
Molecular Weight:
77.15
AlogP:
-0.13
PSA:
26.02
HBD:
2.0
HBA:
#RotB:
1.0
Source:
FAMCICLOVIR
(1994)
Small molecule
Human herpesvirus 1 DNA polymerase inhibitor
ORAL
Approved
Autoimmune Diseases; Eye Infections; Herpes Genitalis; Herpes Labialis; Herpes Zoster; Virus Diseases
FAMCICLOVIR
×
Maximum Phase:
4
First Approval:
1994
UNII:
QIC03ANI02
Molecule Type:
Small molecule
Molecular Formula:
C14H19N5O4
Molecular Weight:
321.34
AlogP:
0.54
PSA:
122.22
HBD:
1.0
HBA:
#RotB:
7.0
Source:
SPIRAPRIL
(1994)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
SPIRAPRIL
×
Maximum Phase:
4
First Approval:
1994
UNII:
96U2K78I3V
Molecule Type:
Small molecule
Molecular Formula:
C22H30N2O5S2
Molecular Weight:
466.63
AlogP:
2.39
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
VINORELBINE
(1994)
Small molecule
Unknown
Unknown
Approved
Neoplasms
VINORELBINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
Q6C979R91Y
Molecule Type:
Small molecule
Molecular Formula:
C45H54N4O8
Molecular Weight:
778.95
AlogP:
4.75
PSA:
133.87
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TECHNETIUM TC 99M BICISATE
(1994)
Small molecule
Unknown
Unknown
Approved
Unknown
TECHNETIUM TC 99M BICISATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
H25WJA31XE
Molecule Type:
Small molecule
Molecular Formula:
C12H20N2O5S2Tc
Molecular Weight:
435.34
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FLUVOXAMINE MALEATE
(1994)
Small molecule
Serotonin transporter inhibitor
ORAL
Approved
Obsessive-Compulsive Disorder
FLUVOXAMINE MALEATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
5LGN83G74V
Molecule Type:
Small molecule
Molecular Formula:
C19H25F3N2O6
Molecular Weight:
434.41
AlogP:
3.2
PSA:
56.84
HBD:
1.0
HBA:
#RotB:
9.0
Source:
DORZOLAMIDE
(1994)
Small molecule
Unknown
Unknown
Approved
Glaucoma
DORZOLAMIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
9JDX055TW1
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O4S3
Molecular Weight:
324.45
AlogP:
0.61
PSA:
106.33
HBD:
2.0
HBA:
#RotB:
3.0
Source:
NEFAZODONE HYDROCHLORIDE
(1994)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depression; Depressive Disorder, Major
NEFAZODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
27X63J94GR
Molecule Type:
Small molecule
Molecular Formula:
C25H33Cl2N5O2
Molecular Weight:
506.48
AlogP:
3.55
PSA:
55.53
HBD:
0.0
HBA:
#RotB:
10.0
Source:
NEFAZODONE
(1994)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
NEFAZODONE
×
Maximum Phase:
4
First Approval:
1994
UNII:
59H4FCV1TF
Molecule Type:
Small molecule
Molecular Formula:
C25H32ClN5O2
Molecular Weight:
470.02
AlogP:
3.55
PSA:
55.53
HBD:
0.0
HBA:
#RotB:
10.0
Source:
SALMETEROL
(1994)
Small molecule
Unknown
Unknown
Approved
Lung Diseases, Obstructive
SALMETEROL
×
Maximum Phase:
4
First Approval:
1994
UNII:
2I4BC502BT
Molecule Type:
Small molecule
Molecular Formula:
C25H37NO4
Molecular Weight:
415.57
AlogP:
4.11
PSA:
81.95
HBD:
4.0
HBA:
#RotB:
16.0
Source:
ACRIVASTINE
(1994)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Hypersensitivity
ACRIVASTINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
A20F9XAI7W
Molecule Type:
Small molecule
Molecular Formula:
C22H24N2O2
Molecular Weight:
348.45
AlogP:
4.02
PSA:
53.43
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ANTAZOLINE PHOSPHATE
(1994)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Unknown
ANTAZOLINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
VPR5FPH326
Molecule Type:
Small molecule
Molecular Formula:
C17H22N3O4P
Molecular Weight:
363.35
AlogP:
2.69
PSA:
27.63
HBD:
1.0
HBA:
#RotB:
5.0
Source:
STAVUDINE
(1994)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
STAVUDINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
BO9LE4QFZF
Molecule Type:
Small molecule
Molecular Formula:
C10H12N2O4
Molecular Weight:
224.22
AlogP:
-0.71
PSA:
84.32
HBD:
2.0
HBA:
#RotB:
2.0
Source:
FLUVOXAMINE
(1994)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
FLUVOXAMINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
O4L1XPO44W
Molecule Type:
Small molecule
Molecular Formula:
C15H21F3N2O2
Molecular Weight:
318.34
AlogP:
3.2
PSA:
56.84
HBD:
1.0
HBA:
#RotB:
9.0
Source:
1
2
…
41
42
43
44
45
46
47
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA